Independent of traditional cardiovascular risk factors, carriers of CHIP have a risk of coronary artery disease almost twice that of non-carriers, and a risk of myocardial infarction (MI) 4 times that of non-carriers [13]. This evidence concerns the gene STUB1 and coronary artery disorder.